Literatur
Hanks, G. E., T. E. Schultheiss, A. L. Hanlon et al.: Optimization of conformal radiation treatment of prostate cancer, report of a dose escalation study. In press.
Herold, D., G. Hanks, B. Movsas et al. Postradiotherapy PSA nadirs fail to support dose escalation study in patients with pretreatment PSA values <10 ng/ml. Radiat. Oncol. Invest. 5 (1997), 15–19.
Lee, W. R., A. L. Hanlon, G. E. Hanks: Prostate specific antigen nadir following external beam radiation therapy for clinically localizend prostate cancer, the relationship between nadir level and disease-free survival. In press.
Tibbs, M. K., A. L. Zietman, K. C. Dallow et al. Biochemical out-come following external beam radiation therapy for T1-2 prostate carcinoma: the importance of achieving an undetectable nadir PSA. Int. J. Radiat. Oncol. Biol. Phys. 32 (1995), 230.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sack, H. Die Bestimmung des PSA-Nadirs nach Strahlentherapie kann die Dosissteigerungsstudie an Patienten mit prätherapeutischen PSA-Werten < 10 ng/ml nicht bestätigen. Strahlenther. Onkol. 173, 529 (1997). https://doi.org/10.1007/BF03038470
Issue Date:
DOI: https://doi.org/10.1007/BF03038470